Race Oncology (Race Oncology) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Race Oncology Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Race Oncology's Cash from Discontinued Operating Activities for the six months ended in Dec. 2023 was $0.00 Mil. It means Race Oncology received $0.00 Mil from discontinued investing activities. Race Oncology's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Race Oncology Cash from Discontinued Operating Activities Historical Data

The historical data trend for Race Oncology's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Race Oncology Cash from Discontinued Operating Activities Chart

Race Oncology Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

Race Oncology Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial										-	-	-	-	-

Race Oncology Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Race Oncology Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Race Oncology's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Race Oncology (Race Oncology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (OTCPK:RAONF) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

RAC:Australia

Address

1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000

Website

https://www.raceoncology.com

Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.

Race Oncology (Race Oncology) Headlines

From GuruFocus

Race executes agreement with Ardena for GMP manufacturing of RC220

By PRNewswire • 07-12-2023

Race Strategic Update August 2023

By PRNewswire • 08-08-2023

Race executes global license agreement with City of Hope to access FTO IP

By PRNewswire • 07-10-2023